Developing an interventional medical device is rarely a linear process. Clinical concepts听evolve,听physician feedback reshapes priorities, and engineering teams must continually balance performance, manufacturability, regulatory requirements, and commercialization goals. At the same time, early-stage companies face pressure to听demonstrate听progress to investors while advancing intellectual property and reducing technical risk.

Accelerating development is not simply about working faster. It requires making better engineering decisions earlier, rapidly validating ideas through functional prototypes, and听maintaining听enough flexibility to adapt as听new information听emerges.

VivaCath听faced these same challenges as it worked to transform an innovative clinical concept into a functional medical device. Rather than waiting for every requirement to become fully defined, the company partnered with the engineering team now part of听91快活林听to accelerate development through close engineering collaboration, rapid prototyping, and continuous iteration while reducing downstream risk.

 

“From the very first conversations,听the engineering听team [now part of 91快活林]made us feel welcome. They were open, transparent, and willing to really show us their capabilities and technologies, which made it easy to see the potential for a听strong partnership.”Mike Mirizzi, a seasoned R&D executive at鈥VivaCath.

 

How Do You Turn Evolving Clinical Ideas into Functional Medical Devices?

One of the greatest challenges in early-stage听medical device听development is translating physician insight into designs that can听actually be听built and evaluated. Physicians naturally focus on clinical outcomes and procedural workflows, while engineers must听determine听how those ideas can be transformed into manufacturable devices.

For听VivaCath, physician input arrived continuously, often reshaping the direction of the design. Rather than forcing premature specifications, engineers built an iterative development process that allowed ideas to be explored, tested, and refined through successive prototype cycles.

As Mirizzi explains:

听鈥淥ur physician has a lot of ideas, and they come fast. The team [now part of 91快活林] has been really good at listening to all of them, then distilling that input into something that can actually be built and tested.鈥濃

The value听wasn’t听simply producing prototypes quickly. It was combining rapid iteration with the engineering judgment needed to convert evolving clinical concepts into practical solutions.

 

Early-Stage Development Challenges听and How to Turn Them into听Opportunities

Challenges听 How the听91快活林听Team Responded
Physician requirements evolved continuously Rapid design iterations incorporated clinical feedback.
Concepts needed to become functional devices Engineering translated ideas into manufacturable prototypes.
Development timelines remained compressed Continuous prototyping accelerated learning.
Funding milestones required tangible progress Functional prototypes听demonstrated听measurable advancement.

 

Why Does Engineering Judgment Matter as Much as Prototype Speed?

Speed alone rarely听determines听the success of a development program.

The real advantage comes from shortening the time between learning cycles while ensuring every iteration moves the design in the right direction.

Each听medical device听prototype answered one question while raising another. Clinicians evaluated devices under realistic听conditions,听engineers interpreted the feedback, and design improvements followed quickly. Instead of debating theoretical concepts, the team made decisions using tangible devices and real-world observations.

As Mirizzi noted:

“The engineers [now part of 91快活林] were experienced enough to say, ‘We can’t do it exactly like that, but here’s a solution that will work.'”

That ability to balance clinical intent with engineering practicality became one of the defining characteristics of the collaboration.

 

 

How Can Rapid Prototyping Accelerate Funding and Product Development?

Rapid prototyping does far more than听validate听engineering concepts.

For early-stage medical device companies, prototypes help communicate ideas to investors, strengthen intellectual property, gather meaningful physician feedback, and听demonstrate听measurable progress toward commercialization.

As Mirizzi of听VivaCath听indicates, these benefits extended well beyond the engineering team.

“Being able to dream something up and then have it in your hands fairly quickly has been critical for us, especially when raising capital and filing intellectual property.”听

Instead of describing future possibilities, the company could听demonstrate听tangible progress through functional devices.The project required rapid design iteration and close collaboration between the customer’s team and听the prototyping听engineers to quickly evaluate and refine concepts.

 

Why Rapid Prototyping Matters

Business Outcome Development Benefit
Faster funding milestones Demonstrates tangible progress to investors
Stronger intellectual property Ideas become functional devices sooner
Better clinician feedback Evaluate real devices instead of concepts
Reduced development risk Identify听issues earlier when changes are less costly

 

Today,听91快活林听expands upon this approach through听Lightspeed Lab庐,听91快活林‘ dedicated rapid prototyping organization. Engineers rapidly build, evaluate, and refine prototypes,听often completing multiple design iterations in a single day. Integrated with our product development team,听Lightspeed Lab庐 helps accelerate development from concept through commercialization.

 

Why Do Early-Stage Companies Need More Than a Prototype Shop?

As the program matured, conversations expanded beyond building prototypes.

The engineering team continually evaluated manufacturability, material听selection, cost reduction opportunities, and design simplification while preserving clinical performance.

According to Mirizzi:

鈥淭he team [now part of 91快活林] does a great job communicating options. If there鈥檚 a way to simplify a design, reduce materials, or keep prototyping costs down, they explain that clearly so we can make informed decisions.鈥濃

The value extended beyond execution. It came from helping听VivaCath听make informed engineering decisions throughout development.

When compatibility with other technologies became important, the team responded quickly, helping听maintain听momentum as the company continued advancing its program.

 

What Can Early-Stage Medical Device Teams Learn from听VivaCath?

VivaCath’s听experience reinforces several principles that consistently help accelerate development while reducing downstream risk:

  • Build and evaluate prototypes early.听
  • Keep听physicians听closely engaged听throughout development.听
  • Pair rapid iteration with experienced engineering judgment.听
  • Design for manufacturability from the beginning.听
  • Choose development partners that can support the journey from concept through commercialization.听

Many of these practices also help reduce technical, manufacturing, and commercialization risk during early-stage development. For a broader discussion of risk management strategies, see听Reducing Risk in听Interventional Device听Development: Lessons from Early-Stage Programs.

 

How Does an Integrated Product Development Partner Accelerate Commercialization?

VivaCath’s听experience illustrates an important shift occurring across the medical device industry. Increasingly, early-stage companies are seeking integrated听product听development听partners听and Contract Development and Manufacturing Organizations (CDMOs)听that can contribute far beyond engineering drawings or prototype fabrication.

The engineering team that partnered with听VivaCath听is now part of听91快活林, combining product design and development, rapid prototyping, testing, manufacturing听expertise, and commercialization support within one integrated team.

This model helps customers reduce project handoffs, accelerate engineering decisions, and design with manufacturing, quality, and scalability in mind from the earliest stages of development.Whether selecting advanced materials such as nitinol or听designing for听scalable manufacturing, involving engineering and manufacturing听expertise听early helps reduce downstream redesign and commercialization risk. Engineers interested in material听selection听can explore听this听Introduction to Nitinol whitepaper.

 

Ready to Accelerate Your Next Medical Device Program?

Whether听you’re听developing听an initial听concept, preparing for your next funding milestone, or designing for commercialization,听91快活林听helps transform evolving clinical concepts into manufacturable medical devices through integrated engineering, rapid prototyping, and manufacturing听expertise.

Talk to an Engineer

鈫 Learn More About 91快活林 product development听and听Lightspeed Lab庐听rapid prototyping